Skip to main content

Advertisement

Log in

Prognostic Value of CEA and CA 19-9 Tumor Markers Combined with Cytology from Peritoneal Fluid in Colorectal Cancer

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Early diagnosis and management of peritoneal metastases from colorectal cancer patients are difficult clinical challenges. The aims of this study were to evaluate the clinical significance of tumor markers and cytology in peritoneal effusions (PE) and peritoneal irrigation fluid (PI) and to determine their value as prognostic indicators in this disease.

Methods

Two hundred thirty-four consecutive patients who underwent abdominal surgery for colorectal cancer from January 2006 to December 2007 were included, and tumor markers and cytology in PE and PI were analyzed prospectively.

Results

The incidence of free cancer cells retrieved from peritoneal samples was 7.9%. Cytology was positive in 40.0% by Papanicolaou and Giemsa staining, 73.3% by hematoxylin and eosin staining of cell blocks, and 66.7% by carcinoembryonic antigen (CEA) and calretinin immunohistochemistry. Multivariate analysis revealed that peritoneal CEA and cancer antigen (CA) 19–9 in PI were correlated with peritoneal metastasis and cytology. Level of peritoneal fluid CEA was statistically significantly correlated with recurrence and peritoneal metastatic recurrence in patients with negative peritoneal cytology. Cytology, peritoneal CEA, and peritoneal CA 19-9 showed correlations with cancer-free survival and overall survival.

Conclusions

These correlations demonstrate the importance of continuous follow-up of peritoneal metastasis if there is positive cytology or an increase in CEA and CA 19-9 in peritoneal fluid.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Shen-Gunther J, Mannel RS. Ascites as a predictor of ovarian malignancy. Gynecol Oncol. 2002;87:77–83.

    Article  PubMed  Google Scholar 

  2. Yamamoto S, Akasu T, Fujita S, Moriya Y. Long-term prognostic value of conventional peritoneal cytology after curative resection for colorectal carcinoma. Jpn J Clin Oncol. 2003;33:33–7.

    Article  PubMed  Google Scholar 

  3. Hase K, Ueno H, Kuranaga N, Utsunomiya K, Kanabe S, Mochizuki H. Intraperitoneal exfoliated cancer cells in patients with colorectal cancer. Dis Colon Rectum. 1998;41:1134–40.

    Article  PubMed  CAS  Google Scholar 

  4. Hermanek P, Hutter RV, Sobin LH, Wittekind C. International Union Against Cancer: classification of isolated tumor cells and micrometastasis. Cancer. 1997;86:2668–73.

    Article  Google Scholar 

  5. Fiegl M, Haun M, Massoner A, Krugmann J, et al. Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions. J Clin Oncol. 2004;22:474–83.

    Article  PubMed  CAS  Google Scholar 

  6. Lee IK, Yi JM, Lee YS, et al. The significance of peritoneal effusion in colorectal cancer. J Korean Soc Coloproctol. 2006;22:308–13.

    Google Scholar 

  7. Nagy JA, Masse EM, Herzberg KT, et al. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res. 1995;55:360–8.

    PubMed  CAS  Google Scholar 

  8. Vogel P, Rüschoff J, Kümmel, et al. Prognostic value of microscopic peritoneal dissemination: comparison between colon and gastric cancer. Dis Colon Rectum. 2000;43:92–100.

    Article  PubMed  CAS  Google Scholar 

  9. Park JD, Kim HC, Cho YK, Yu CS, Kim JC. The clinical significance of carcinoembrionic antigen and CA 72-4 assays of peritoneal fluid in colorectal carcinomas. J Korean Soc Coloproctol. 2002;18:303–36.

    Google Scholar 

  10. Kanellos I, Demetriades H, Zintzaras E, Mandrali A, Mantzoros I, Betsis D. Incidence and prognostic value of positive peritoneal cytology in colorectal cancer. Dis Colon Rectum. 2003;46:535–9.

    Article  PubMed  CAS  Google Scholar 

  11. Porcel JM, Vives M, Esquerda A, Salud A, Perez B, Rodriguez-Panadero F. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest. 2004;126:1757–63.

    Article  PubMed  Google Scholar 

  12. Alexandrakis MG, Moschandrea JA, Koulocheri SA, Kouroumalis E, Eliopoulos GD. Discimination between malignant and nonmalignant ascites using serum and ascitic fluid proteins in multivariate analysis model. Dig Dis Sci. 2000;45:500–8.

    Article  PubMed  CAS  Google Scholar 

  13. Yamamoto M, Baba H, Kakeji Y, et al. Prognostic significance of tumor markers in peritoneal lavage in advanced gastric cancer. Oncology. 2004;67:19–26.

    Article  PubMed  CAS  Google Scholar 

  14. Kanellos I, Zacharakis E, Kanellos D, Pramateftakis MG, Betsis D. Prognostic significance of CEA levels and positive cytology in peritoneal washings in patients with colorectal cancer. Colorect Dis. 2006;8:436–40.

    Article  CAS  Google Scholar 

  15. Gozalan U, Yast AC, Yuksek YN, Reis E, Kama NA. Peritoneal cytology in colorectal cancer: incidence and prognostic value. Am J Surg. 2007;193:672–5.

    Article  PubMed  Google Scholar 

  16. Horattas MC, Evasovich MR, Topham N. Colorectal carcinoma and the relationship of peritoneal cytology. Am J Surg. 1997;174:334–8.

    Article  PubMed  CAS  Google Scholar 

  17. Simsir A, Fetsch P, Abati A. Carlretinin immunostaining in benign and malignant pleural effusions. Diagn Cytopathol. 2001;24:149–52.

    Article  PubMed  CAS  Google Scholar 

  18. Su XY, Li GD, Liu HB, Jiang LL. Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion. Ai Zheng. 2004;23:1185–9.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

I.K.L. was supported by CJ-Aventis New Research Grant from Korean Society of Coloproctology and a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (A080760).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to In Kyu Lee MD or Seong Taek Oh MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, I.K., Kim, D.H., Gorden, D.L. et al. Prognostic Value of CEA and CA 19-9 Tumor Markers Combined with Cytology from Peritoneal Fluid in Colorectal Cancer. Ann Surg Oncol 16, 861–870 (2009). https://doi.org/10.1245/s10434-008-0294-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-008-0294-3

Keywords

Navigation